2,037
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice

, , , , , , , & show all
Article: 2197075 | Received 16 Jan 2023, Accepted 26 Mar 2023, Published online: 05 Apr 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.